⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
INCY News
Incyte Genomics Inc
Incyte kondigt goedkeuring van de Europese Commissie aan voor Zynyz ® (retifanlimab) voor de eerstelijnsbehandeling van gevorderd plaveiselcelcarcinoom van het anale kanaal (SCAC)
businesswire.com
INCY
Incyte anuncia que la Comisión Europea ha aprobado Zynyz ® (retifanlimab) para el tratamiento de primera línea del carcinoma de células escamosas del canal anal avanzado
businesswire.com
INCY
Form 8-K
sec.gov
INCY
Incyte Announces the European Commission Approval of Zynyz ® (retifanlimab) for the First-Line Treatment of Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC)
businesswire.com
INCY
Biliary Tract Cancer Market is Predicted to Exhibit Remarkable Growth at a CAGR of 10.1% During the Forecast Period (2025-2034) | DelveInsight
prnewswire.com
CMPX
MRK
PFE
BOLD
REPL
RDHL
RLAY
LLY
INCY
JAZZ
Lilly's Olumiant (baricitinib) recommended by CHMP for approval of expanded use in the European Union for adolescents with severe alopecia areata
prnewswire.com
LLY
INCY
CMS (867.HK/8A8.SG): NDA for Additional Indication Atopic Dermatitis (AD) for Ruxolitinib Phosphate Cream Accepted and Granted Priority Review in China
globenewswire.com
INCY
More Than 30 Million Americans Living with Rare Diseases
prnewswire.com
AMGN
SNY
AGIO
ASND
DVA
INCY
NVS
PFE
REGN
UCB
Alopecia Areata Market Set to Expand by 2036, Due to the Emergence of Novel Drug Classes Such as OX40L Inhibitors, IL-2 Inhibitors, IL-7Rα, and Others | DelveInsight
prnewswire.com
ABBV
QTTB
HCWB
NKTR
LLY
INCY
PFE
JAK Inhibitors Competitive Landscape Report 2026: Comprehensive Insights on 40+ Companies and 45+ Drugs by Company, Product Type, Development Stage, Administration Route, Molecule Type
globenewswire.com
LLY
ABBV
INCY